23 results
424B3
SHPH
Shuttle Pharmaceuticals Holdings Inc
22 Mar 24
Prospectus supplement
6:07am
derivative financial instruments classified as a liability, the Company uses a Monte Carlo valuation model to value the derivative instruments … , is evaluated at the end of each reporting period.
For our derivative financial instruments classified as equity, the Company used a Black Scholes valuation
8-K
EX-10.1
fufdldpttlth5 4v
30 Oct 23
Shuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License Agreement
5:14pm
424B3
iw5ug3o
24 Aug 23
Prospectus supplement
2:00pm
10-Q
4cmue5hi02ul
14 Nov 22
Quarterly report
5:21pm
DRS
bo40olrvnyk 25g8nj3
29 Sep 22
Draft registration statement
12:00am
424B4
e1yznfa3ifjqt9l31n
31 Aug 22
Prospectus supplement with pricing info
6:16am
S-1
ny66lpq ik
3 Jun 22
IPO registration
5:32pm
S-1
EX-10.31
de4ta co63
3 Jun 22
IPO registration
5:32pm
S-1
EX-10.14
3lx5sx v3q7p4r9unv
3 Jun 22
IPO registration
5:32pm